An interesting piece from The Guardian arising from comments made by the shadow chancellor, John McDonnell, about whether the patent box scheme is actually a tax loophole for big pharma companies. One might suggest it's a bit premature to make such claims, particularly as the scheme can also benefit smaller UK companies with qualifying IP and R&D expenditure too.